Modelling the prevalence of hepatitis C virus amongst blood donors in Libya: An investigation of providing a preventive strategy.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  World Journal of Virology

• Publication date

  2016-02-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.5501/wjv.v5.i1.14PMID 26870670PMCID PMC4735550
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The assessment of efficiency and coordination within the Libyan health care system during the armed conflict-2011

  2016cited by this paper
• Geographic distribution of HCV genotypes in Libya and analysis of risk factors involved in their transmission

  2015cited by this paper
• Libyan armed conflict 2011: Mortality, injury and population displacement

  2015cited by this paper
• Viral Haemorrhagic Fever in North Africa; an Evolving Emergency

  2015cited by this paper
• Toward a more accurate estimate of the prevalence of hepatitis C in the United States

  2015cited by this paper
• Trends in Epidemiology, Treatment, and Survival of Hepatocellular Carcinoma Patients Between 1998 and 2009: An Analysis of 1066 Cases of a German HCC Registry

  2014cited by this paper
• Deaths among people with hepatitis C in New York City, 2000-2011.

  2014cited by this paper
• Prevalence of hepatitis B and hepatitis C infection in Libya: results from a national population based survey

  2014cited by this paper
• Hepatitis C recurrence: the Achilles heel of liver transplantation

  2014cited by this paper
• Applications and Comparisons of Four Time Series Models in Epidemiological Surveillance Data

  2014cited by this paper
• Treatment of Hepatitis C with An Interferon-Based Lead-In Phase: A Perspective from Mathematical Modelling

  2014cited by this paper
• Correcting and combining time series forecasters

  2014cited by this paper
• Global epidemiology of hepatitis C virus infection: New estimates of age‐specific antibody to HCV seroprevalence

  2013cited by this paper
• Modelling the prevalence of HCV amongst people who inject drugs: an investigation into the risks associated with injecting paraphernalia sharing.

  2013cited by this paper
• The development of a combined mathematical model to forecast the incidence of hepatitis E in Shanghai, China

  2013cited by this paper
• Forecasting the Number of Human Immunodeficiency Virus Infections in the Korean Population Using the Autoregressive Integrated Moving Average Model

  2013cited by this paper
• Trends in transfusion‐transmissible infections among Australian blood donors from 2005 to 2010

  2013cited by this paper
• Towards realistic estimates of HCV incidence in Egypt

  2013cited by this paper
• The prevalence and trends of transfusion-transmissible infectious pathogens among first-time, voluntary blood donors in Xi'an, China between 1999 and 2009.

  2013cited by this paper
• Stochastic modelling of intra-household transmission of hepatitis C virus: evidence for substantial non-sexual infection.

  2013cited by this paper
• Prevalence and trend of hepatitis C virus infection among blood donors in Iran: A systematic review and meta-analysis

  2013cited by this paper
• Hepatitis C virus (HCV) infection in Africa: a review

  2013cited by this paper
• Hepatitis B virus in the Maghreb Region: from epidemiology to prospective research

  2013cited by this paper
• Seroprevalence of Hepatitis B and C Infections among Healthy Volunteer Blood Donors in the Central California Valley

  2012cited by this paper
• HIV-, HCV-, HBV- und Syphilissurveillance unter Blutspendern in Deutschland 2008–2010

  2012cited by this paper
• The management of blood safety in the presence of uncertain risk: a United kingdom perspective.

  2012cited by this paper
• [HIV, HCV, HBV and syphilis surveillance among blood donors in Germany 2008-2010].

  2012cited by this paper
• Epidemiological Pattern of Hepatitis B and Hepatitis C as Etiological Agents for Hepatocellular Carcinoma in Iran and Worldwide

  2012cited by this paper
• Influence of Healthcare-Associated Factors on the Efficacy of Hepatitis C Therapy

  2012cited by this paper
• Mathematical modelling of HCV infection: what can it teach us in the era of direct-acting antiviral agents?

  2012cited by this paper
• Hepatitis C Virus in Arab World: A State of Concern

  2012cited by this paper
• Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors

  2012cited by this paper
• Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010

  2012cited by this paper
• Forecasting incidence of hemorrhagic fever with renal syndrome in China using ARIMA model

  2011cited by this paper
• Applying a system approach to forecast the total hepatitis C virus‐infected population size: model validation using US data

  2011cited by this paper
• Trends and projections of hepatitis C virus epidemiology in Latin America

  2011cited by this paper
• Epidemiological manifestations of hepatitis C virus genotypes and its association with potential risk factors among Libyan patients

  2010cited by this paper
• Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians

  2010cited by this paper
• Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing

  2010cited by this paper
• Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales

  2006cited by this paper
• Trends in the

  2003cited by this paper
• Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk.

  2002cited by this paper
• Box-Jenkins modelling of some viral infectious diseases.

  1986cited by this paper

• Seroprevalence and associated risk factors of HBV and HCV infections in the population of Ghudduwah Village, South Libya.

  2025influential citation
• Hepatitis C in North Africa: A Comprehensive Review of Epidemiology, Genotypic Diversity, and Hepatocellular Carcinoma

  2025cites this paper
• Trends of the incidence rate of Hepatitis C in Changsha, China, 2005 to 2023 and Its Prediction to 2025.

  2025cites this paper
• Modelling the epidemic spread of COVID-19 virus infection in Northern African countries

  2020cites this paper
• Spatiotemporal analysis and hotspots detection of COVID-19 using geographic information system (March and April, 2020)

  2020cites this paper
• The geographic variation and spatiotemporal distribution of hepatitis C virus infection in Libya: 2007–2016

  2018cites this paper
• A Seven Year Review of the Seroprevalence of Transfusion Transmitted Infections in a Hospital Based Blood Bank in Ibadan, Nigeria

  2017cites this paper
• Seroprevalence of Hepatitis C Virus among Blood Donors in Middle Eastern Countries: A Systematic Review and Meta-Analysis

  2017influential citation
• Hepatitis C Virus in North Africa: An Emerging Threat

  2016cites this paper
• Geographic integration of hepatitis C virus: A global threat

  2016cites this paper